Trial Profile
A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease (GLAZED Trial)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary) ; Pioglitazone
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- Acronyms GLAZED
- 22 Oct 2014 New trial record